Messenger RNA capping and methylation in pneumoviruses
Messenger RNA capping and methylation in pneumoviruses
批准号:
10548203
负责人:
Jianrong Li
金额:
$46.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
未结题
起止时间:
2010-12-01 至 2025-01-31
关键词:
AcuteAdenosineAnimal ModelAntiviral AgentsAttenuated VaccinesBindingBiochemicalBiological ProcessCellsChildComplexCotton RatsDevelopmentEconomicsElderlyEmotionalEnzymesEpithelial CellsEukaryotaFDA approvedFamilyGene ExpressionGenomeGrantHIVHela CellsHepatitis C virusHumanHuman MetapneumovirusImmunityImmunocompromised HostIndividualInfantKnock-outLife Cycle StagesMediatingMedicalMessenger RNAMethylationMethyltransferaseModelingModificationMononegaviralesMutationNucleocapsidPathogenesisPneumovirusProteinsRNARNA CapsRNA StabilityRNA metabolismRNA methylationReaderRecombinantsResearchRespiratory syncytial virusRibonucleoproteinsRoleSeriesSiteSystemTestingTranslationsVaccinesVesicular stomatitis Indiana virusViralViral GenesViral GenomeViral PathogenesisViral Respiratory Tract InfectionVirulenceVirusVirus ReplicationWorkairway epitheliumantiviral drug developmentattenuationgenetic approachgenetic informationin vivoinfluenzavirusknock-downmRNA TranslationmRNA cappingnovelnovel strategiesnovel vaccinesoverexpressionpathogenposttranscriptionalpublic health relevancerational designrecombinant virusreverse geneticsvaccine candidateviral RNA
中文摘要
摘要
这项申请是为了更新一项研究肺病毒RNA甲基化的资助。肺炎病毒科是一种新病毒
家族,于2016年通过将副粘病毒亚科肺炎病毒提升为家族地位而创建。的
肺炎病毒科包括两种医学上重要的病原体,人呼吸道合胞病毒(RSV)和
人偏肺病毒(human metapneumovirus,hMPV)是引起急性病毒性呼吸道感染的主要病原体
婴儿、幼儿、老年人和免疫功能低下个体的感染。尽管面临巨大
这些病毒造成的经济损失和情感负担,目前没有疫苗或抗病毒药物。
开发此类制剂需要更好地了解其生命周期的各个方面。在最后一次拨款中
在此期间,我们揭示了肺炎病毒中mRNA加帽和帽甲基化的独特机制。我们
最近发现,肺病毒基因组,反基因组和mRNA也在内部甲基化,
腺苷残基通过宿主m6 A甲基转移酶复合物形成N6-甲基腺苷(m6 A)。虽然m6 a
20世纪70年代初在病毒RNA中发现了甲基化,m6 A在病毒生命周期中的生物学功能,
发病机制和免疫力四十年来一直是个谜。我们发现,内部m6 A
病毒RNA中的甲基化促进肺病毒复制和基因表达。当前的目标
应用是确定内部m6 A甲基化在肺炎病毒复制和发病机制中的作用
在体内;以及确定m6 A甲基化调节肺病毒生命周期机制。我们的具体
目的是:(1)确定调节肺炎病毒复制和基因表达的宿主m6 A机制;(2)
确定内部m6 A促进肺病毒复制和基因表达的机制;
(3)在棉鼠模型中确定m6 A甲基化在肺病毒复制和发病机制中的作用。的
这项工作的成功完成不仅将促进我们对m6 A甲基化在调节中的理解,
肺病毒的生命周期和发病机制,而且还提供了一种新的方法,用于开发活减毒
通过抑制病毒m6 A甲基化来制备候选疫苗和抗病毒药物。
英文摘要
Abstract
This application is to renew a grant to study RNA methylation in pneumoviruses. Pneumoviridae is a new virus
family, created in 2016 by elevating the paramyxoviral subfamily Pneumovirinae to family status. The
Pneumoviridae family includes two medically important pathogens, human respiratory syncytial virus (RSV) and
human metapneumovirus (hMPV), which are the leading causative agents of acute viral respiratory tract
infections in infants, young children, the elderly, and immunocompromised individuals. Despite the enormous
economic loss and emotional burden these viruses cause, no vaccines or anti-viral drugs are currently available.
Development of such agents requires a better understanding of all aspects of their life cycle. In the last grant
period, we have revealed the unique mechanism of mRNA capping and cap methylation in pneumoviruses. We
recently discovered that pneumovirus genome, antigenome, and mRNAs are also methylated at internal
adenosine residues to form N6-methyladenosine (m6A) by host m6A methyltransferase complex. Although m6A
methylation has been discovered in viral RNA in early 1970s, the biological function of m6A in the virus life cycle,
pathogenesis, and immunity has been a mystery for four decades. We have found that the internal m6A
methylation in viral RNAs promotes pneumovirus replication and gene expression. The objectives of the current
application are to determine the roles of internal m6A methylation in pneumovirus replication and pathogenesis
in vivo; and to define mechanism(s) by which m6A methylation modulate pneumovirus life cycle. Our Specific
Aims are: (1) to define the host m6A machinery that regulates pneumovirus replication and gene expression; (2)
to define the mechanism(s) by which internal m6A promote pneumovirus replication and gene expression; and
(3) to define the roles of m6A methylation in pneumovirus replication and pathogenesis in a cotton rat model. The
successful completion of this work will not only advance our understanding of m6A methylation in regulating
pneumovirus life cycle and pathogenesis, but also provide a novel approach for developing live attenuated
vaccine candidates and antiviral drugs by inhibiting viral m6A methylation.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS-CoV-2 infection.
表达由六个而不是两个脯氨酸稳定的融合前刺突蛋白的重组麻疹病毒对 SARS-CoV-2 感染更有效。
DOI:
10.1002/jmv.28687
发表时间:
2023
期刊:
Journal of medical virology
影响因子:
12.7
作者:
[Zhang,Yuexiu, Lu,Mijia, Thongpan,Ilada, Xu,Jiayu, Kc,Mahesh, Dravid,Piyush, Trivedi,Sheetal, Sharma,Himanshu, Liang,Xueya, Kapoor,Amit, Peeples,MarkE, Li,Jianrong]
通讯作者:
Li,Jianrong
Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion.
SARS-CoV-2 BA.2.87.1 和 JN.1 变体在免疫逃避、抗原性和细胞-细胞融合方面的独特模式。
DOI:
10.1101/2024.03.11.583978
发表时间:
2024
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Li,Pei, Liu,Yajie, Faraone,Julia, Hsu,ChengChih, Chamblee,Michelle, Zheng,Yi-Min, Carlin,Claire, Bednash,JosephS, Horowitz,JeffreyC, Mallampalli,RamaK, Saif,LindaJ, Oltz,EugeneM, Jones,Daniel, Li,Jianrong, Gumina,RichardJ, Liu,Shan-]
通讯作者:
Liu,Shan-
Small Animal Models for Human Metapneumovirus: Cotton Rat is More Permissive than Hamster and Mouse.
人类偏肺病毒的小动物模型:棉鼠比仓鼠和小鼠更容易受到感染。
DOI:
10.3390/pathogens3030633
发表时间:
2014
期刊:
Pathogens (Basel, Switzerland)
影响因子:
--
作者:
[Zhang,Yu, Niewiesk,Stefan, Li,Jianrong]
通讯作者:
Li,Jianrong
DOI:
10.1073/pnas.2110105119
发表时间:
2022-08-30
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[]
通讯作者:
DOI:
10.1128/jvi.00592-21
发表时间:
2021-09-27
期刊:
Journal of virology
影响因子:
5.4
作者:
[Lu M, Zhang Y, Dravid P, Li A, Zeng C, Kc M, Trivedi S, Sharma H, Chaiwatpongsakorn S, Zani A, Kenney A, Cai C, Ye C, Liang X, Qiu J, Martinez-Sobrido L, Yount JS, Boyaka PN, Liu SL, Peeples ME, Kapoor A, Li J]
通讯作者:
Li J
共 13 条
Messenger RNA Capping and Methylation in Pneumoviruses
-
批准号:8050356
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2010
-
负责人:Jianrong Li
-
依托单位:
Messenger RNA Capping and Methylation in Pneumoviruses
-
批准号:8390502
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2010
-
负责人:Jianrong Li
-
依托单位:
Messenger RNA capping and methylation in pneumoviruses
-
批准号:8090031
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2010
-
负责人:Jianrong Li
-
依托单位:
Messenger RNA Capping and Methylation in Pneumoviruses
-
批准号:8204396
-
项目类别:
-
资助金额:$37.28万
-
财政年份:2010
-
负责人:Jianrong Li
-
依托单位:
Messenger RNA Capping and Methylation in Pneumoviruses
-
批准号:8582531
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2010
-
负责人:Jianrong Li
-
依托单位:
Project 3: Dr. Li
-
批准号:9133263
-
项目类别:
-
资助金额:$26.67万
-
财政年份:--
-
负责人:Jianrong Li
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: